Saturday, October 31, 2026

Altus Midstream Company And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

ViaNews Editorial Team

August 27, 2024

Altus Midstream Company  And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) - Altus Midstream Company (ALTM), Cognex Corporation (CGNX), Stifel Financial Corporation (SF) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Altus Midstream Company (ALTM)

61.6% sales growth and 5.48% return on equity

Arcadium Lithium plc engages in the production of lithium chemicals products in the Asia Pacific, North America, Europe, the Middle East, Africa, and Latin America. It offers battery-grade lithium hydroxide, lithium carbonate, butyllithium and high purity lithium metal for electric vehicles, electronics, agricultural, industrial, greases, polymers, pharmaceutical, battery, and aerospace applications. The company also owns interest in various properties located in Argentina, Canada, and Western Australia. Arcadium Lithium plc was founded in 1944 and is based in Shannon, Ireland.

Earnings Per Share

As for profitability, Altus Midstream Company has a trailing twelve months EPS of $0.34.

PE Ratio

Altus Midstream Company has a trailing twelve months price to earnings ratio of 7.88. Meaning, the purchaser of the share is investing $7.88 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.48%.

Yearly Top and Bottom Value

Altus Midstream Company's stock is valued at $2.68 at 11:22 EST, way under its 52-week high of $9.25 and above its 52-week low of $2.50.

2. Cognex Corporation (CGNX)

13.6% sales growth and 5.25% return on equity

Cognex Corporation provides machine vision products that capture and analyze visual information in order to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, aspirin bottles, and automobile tires by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process. The company offers VisionPro software, a suite of patented vision tools for advanced programming; QuickBuild that allows customers to build vision applications with a graphical, flowchart-based programming interface; and Cognex deep learning vision software. It also provides a range of inspection tasks, including part location, identification, measurement, assembly verification, and robotic guidance; vision sensors for vision applications, such as checking the presence and size of parts; and the In-Sight product line of vision systems and sensors. In addition, the company offers DataMan, an image-based barcode readers and barcode verifiers. It sells its products to consumer electronics, automotive, consumer products, food and beverage, pharmaceuticals, and medical devices industries, as well as through a network of distributors and integrators. Cognex Corporation was incorporated in 1981 and is headquartered in Natick, Massachusetts.

Earnings Per Share

As for profitability, Cognex Corporation has a trailing twelve months EPS of $0.45.

PE Ratio

Cognex Corporation has a trailing twelve months price to earnings ratio of 85.56. Meaning, the purchaser of the share is investing $85.56 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.25%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 1.3%, now sitting on 844M for the twelve trailing months.

Sales Growth

Cognex Corporation's sales growth for the next quarter is 13.6%.

Growth Estimates Quarters

The company's growth estimates for the present quarter and the next is 18.8% and 54.5%, respectively.

3. Stifel Financial Corporation (SF)

12.1% sales growth and 10.42% return on equity

Stifel Financial Corp., a financial services and bank holding company, provides retail and institutional wealth management, and investment banking services to individual investors, corporations, municipalities, and institutions in the United States and internationally. It operates in three segments: Global Wealth Management, Institutional Group, and Other. The company provides private client services, including securities transaction and financial planning services; institutional equity and fixed income sales, trading and research, and municipal finance services; investment banking services, such as mergers and acquisitions, public offerings, and private placements; and retail and commercial banking services comprising personal and commercial lending programs, as well as deposit accounts. It participates in and manages underwritings for corporate and public finance; and offers financial advisory and securities brokerage services. The company was founded in 1890 and is headquartered in Saint Louis, Missouri.

Earnings Per Share

As for profitability, Stifel Financial Corporation has a trailing twelve months EPS of $4.72.

PE Ratio

Stifel Financial Corporation has a trailing twelve months price to earnings ratio of 17.3. Meaning, the purchaser of the share is investing $17.3 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.42%.

Yearly Top and Bottom Value

Stifel Financial Corporation's stock is valued at $81.67 at 11:22 EST, under its 52-week high of $90.00 and way above its 52-week low of $54.81.

Revenue Growth

Year-on-year quarterly revenue growth grew by 16.5%, now sitting on 4.55B for the twelve trailing months.

4. Tyler Technologies (TYL)

11.9% sales growth and 7.04% return on equity

Earnings Per Share

As for profitability, Tyler Technologies has a trailing twelve months EPS of $3.88.

PE Ratio

Tyler Technologies has a trailing twelve months price to earnings ratio of 106.54. Meaning, the purchaser of the share is investing $106.54 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.04%.

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com